Effects of ipragliflozin versus metformin in combination with sitagliptin on bone and muscle in Japanese patients with type 2 diabetes mellitus: Subanalysis of a prospective, randomized, controlled study (PRIME‐V study)

AIMS/INTRODUCTION: Recent randomized clinical trials have suggested that sodium–glucose cotransporter 2 inhibitors might reduce cardiovascular events and heart failure, and have renal protective effects. Despite these remarkable benefits, the effects of sodium–glucose cotransporter 2 inhibitors on b...

Descripción completa

Detalles Bibliográficos
Autores principales: Koshizaka, Masaya, Ishikawa, Ko, Ishibashi, Ryoichi, Maezawa, Yoshiro, Sakamoto, Kenichi, Uchida, Daigaku, Nakamura, Susumu, Yamaga, Masaya, Yokoh, Hidetaka, Kobayashi, Akina, Onishi, Shunichiro, Kobayashi, Kazuki, Ogino, Jun, Hashimoto, Naotake, Tokuyama, Hirotake, Shimada, Fumio, Ohara, Emi, Ishikawa, Takahiro, Shoji, Mayumi, Ide, Shintaro, Ide, Kana, Baba, Yusuke, Hattori, Akiko, Kitamoto, Takumi, Horikoshi, Takuro, Shimofusa, Ryouta, Takahashi, Sho, Nagashima, Kengo, Sato, Yasunori, Takemoto, Minoru, Newby, L. Kristin, Yokote, Koutaro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7858125/
https://www.ncbi.nlm.nih.gov/pubmed/32623839
http://dx.doi.org/10.1111/jdi.13340

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7858125/
https://www.ncbi.nlm.nih.gov/pubmed/32623839
http://dx.doi.org/10.1111/jdi.13340

Ejemplares similares